These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 19803538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
    McCullagh L, Walsh C, Barry M.
    Pharmacoeconomics; 2012 Oct 01; 30(10):941-59. PubMed ID: 22667458
    [Abstract] [Full Text] [Related]

  • 3. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E.
    Health Technol Assess; 2009 Oct 01; 13 Suppl 3():43-8. PubMed ID: 19846028
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
    Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M.
    Pharmacoeconomics; 2012 Feb 01; 30(2):87-101. PubMed ID: 22187932
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal.
    Holmes M, Carroll C, Papaioannou D.
    Pharmacoeconomics; 2012 Feb 01; 30(2):137-46. PubMed ID: 22185183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M, Sobieraj DM.
    Pharmacotherapy; 2013 Dec 01; 33(12):1333-40. PubMed ID: 23625693
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
    Holmes M, Carroll C, Papaioannou D.
    Health Technol Assess; 2009 Sep 01; 13 Suppl 2():55-62. PubMed ID: 19804690
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
    Burness CB, McKeage K.
    Drugs; 2012 May 07; 72(7):963-86. PubMed ID: 22564134
    [Abstract] [Full Text] [Related]

  • 16. Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
    Duran A, Sengupta N, Diamantopoulos A, Forster F, Kwong L, Lees M.
    J Med Econ; 2011 May 07; 14(6):824-34. PubMed ID: 22023098
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
    Plumb JM, Clemens A, Monz BU.
    Pharmacoeconomics; 2010 May 07; 28(9):781-2; author reply 782-4, 784-5. PubMed ID: 20824908
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands.
    Postma MJ, Kappelhoff BS, van Hulst M, Brouwers JR.
    J Med Econ; 2012 May 07; 15(5):878-86. PubMed ID: 22563715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.